YaoGeJu

Company directoryChina company filings

Hubei Biocause Heilen Pharmaceutical Co.,Ltd.

As of 18 November 2026, for the company name Hubei Biocause Heilen Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 15 active records with this name as holder; 13 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

22 acceptance records as first applicant, grouped into 12 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Abiraterone Acetate Tablets 2 records · Latest accepted 2026/06/05

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601309Generic2026/06/05Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Yao Yuan Bio Technology (Qi Dong) Co., Ltd. romanizedCDE ↗
CYHS2601308Generic2026/06/05Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Yao Yuan Bio Technology (Qi Dong) Co., Ltd. romanizedCDE ↗
多维元素片(21) · No verified English name 2 records · Latest accepted 2025/05/31

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2501112Supplement2025/05/31Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2200607Supplement2022/04/11Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Atropine Sulfate Injection 1 records · Latest accepted 2025/05/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501817Generic2025/05/20Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Hubei Jin Yao Pharma Co., Ltd. romanizedCDE ↗
Arginine and Ibuprofen Granules 2 records · Latest accepted 2025/02/13

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500727Generic2025/02/13Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHS2500726Generic2025/02/13Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Febuxostat Tablets 2 records · Latest accepted 2024/05/21

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401513Generic2024/05/21Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHS2401512Generic2024/05/21Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Ibuprofen Suspension 2 records · Latest accepted 2024/02/23

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2400680Generic2024/02/23Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Hubei Wei Sen Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2400679Generic2024/02/23Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Hubei Wei Sen Pharmaceutical Co., Ltd. romanizedCDE ↗
Ibuprofen Granules 2 records · Latest accepted 2024/01/30

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2400168Supplement2024/01/30Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2150513Supplement2021/03/04Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Torsemide Injection 2 records · Latest accepted 2023/11/09

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303068Generic2023/11/09Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanizedCDE ↗
CYHS2303067Generic2023/11/09Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanizedCDE ↗
Milrinone Injection 2 records · Latest accepted 2023/10/27

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302916Generic2023/10/27Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Hubei Jin Yao Pharma Co., Ltd. romanizedCDE ↗
CYHS2302915Generic2023/10/27Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Hubei Jin Yao Pharma Co., Ltd. romanizedCDE ↗
Ibuprofen Sustained Release Capsules 1 records · Latest accepted 2023/10/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302627Generic2023/10/08Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Torasemide Tablets 2 records · Latest accepted 2023/07/18

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350575Supplement2023/07/18Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2350574Supplement2023/07/18Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
Ibuprofen Tablets 2 records · Latest accepted 2022/01/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250063Supplement2022/01/24Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗
CYHB2250062Supplement2022/01/24Hubei Biocause Heilen Pharmaceutical Co.,Ltd.CDE ↗

Changes in the last 90 days

1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

No longer listed under review: 1 application

  1. 2026/11/11No longer listed under review

    Atropine Sulfate Injection

    CYHS2501817

    Fact date: 2026/11/11 · Date added to this site: 2026/11/11

    Accepted: 2025/05/20

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗

Under review

2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Abiraterone Acetate Tablets CYHS2601309Generic2026/06/05Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Yao Yuan Bio Technology (Qi Dong) Co., Ltd. romanizedCDE ↗
Abiraterone Acetate Tablets CYHS2601308Generic2026/06/05Hubei Biocause Heilen Pharmaceutical Co.,Ltd.; Yao Yuan Bio Technology (Qi Dong) Co., Ltd. romanizedCDE ↗

Catalogue holder records

15 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Febuxostat TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202556862025/10/14Generic approved under the new chemical-drug registration classificationCDE ↗
Febuxostat TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202556852025/10/14Generic approved under the new chemical-drug registration classificationCDE ↗
Torsemide InjectionHubei Biocause Heilen Pharmaceutical Co.,Ltd.Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized国药准字H202543222025/05/27Generic approved under the new chemical-drug registration classificationCDE ↗
Torsemide InjectionHubei Biocause Heilen Pharmaceutical Co.,Ltd.Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized国药准字H202543232025/05/27Generic approved under the new chemical-drug registration classificationCDE ↗
Ibuprofen Sustained Release CapsulesHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202531962025/01/14Generic approved under the new chemical-drug registration classificationCDE ↗
Ibuprofen GranulesHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202473332024/12/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Milrinone InjectionHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Jin Yao Pharma Co., Ltd. romanized国药准字H202446532024/08/05Generic approved under the new chemical-drug registration classificationCDE ↗
Milrinone InjectionHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Jin Yao Pharma Co., Ltd. romanized国药准字H202446542024/08/05Generic approved under the new chemical-drug registration classificationCDE ↗
Torasemide TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202470992024/05/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Torasemide TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H200400752024/05/13Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ibuprofen TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H420209892023/01/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ibuprofen TabletsHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H199940352023/01/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ibuprofen GranulesHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H200941132022/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Arginine and Ibuprofen GranulesHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202661002026/09/29Generic approved under the new chemical-drug registration classificationCDE ↗
Arginine and Ibuprofen GranulesHubei Biocause Heilen Pharmaceutical Co.,Ltd.Hubei Biocause Heilen Pharmaceutical Co.,Ltd.国药准字H202660992026/09/29Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

13 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
琥珀酸亚铁 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20260000780I2026/09/10CDE ↗
奥美沙坦酯 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20250001003I2025/09/17CDE ↗
盐酸埃克替尼 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20240000578A2026/03/01CDE ↗
精氨酸布洛芬 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20240000003A2026/08/27CDE ↗
盐酸甲氧氯普胺 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20230001040A2025/09/15CDE ↗
醋酸阿比特龙 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20220000319A2025/06/19CDE ↗
硫酸阿托品 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20210000435A2025/06/13CDE ↗
布洛芬 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190008553A2025/08/27CDE ↗
右布洛芬 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190003170A2025/06/13CDE ↗
托拉塞米 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190003152A2025/06/06CDE ↗
奥沙普秦 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190003130A2025/06/06CDE ↗
加替沙星 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190003106A2025/06/06CDE ↗
巴柳氮钠 · No verified English nameHubei Biocause Heilen Pharmaceutical Co.,Ltd.Y20190003099A2025/06/06CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.